Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 93 (2) , 82-91
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (JP 25461700)
This publication has 39 references indexed in Scilit:
- Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis modelJournal of Dermatological Science, 2018
- Skin-Specific CD301b+ Dermal Dendritic Cells Drive IL-17−Mediated Psoriasis-Like Immune Response in MiceJournal of Investigative Dermatology, 2018
- Human β-Defensin 3 and Its Mouse Ortholog Murine β-Defensin 14 Activate Langerhans Cells and Exacerbate Psoriasis-Like Skin Inflammation in MiceJournal of Investigative Dermatology, 2016
- Psoriasis-like skin lesions are dependent on IL-23 but develop in the absence of IL-22 in a model mouseJournal of Dermatological Science, 2014
- Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activationJournal of Dermatological Science, 2013
- Anti-cytokine therapies for psoriasisExperimental Cell Research, 2011
- Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseasesJournal of Dermatological Science, 2008
- Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokinesCurrent Rheumatology Reports, 2007
- Epidermal Langerhans Cell-Deficient Mice Develop Enhanced Contact HypersensitivityImmunity, 2005
- Dynamics and Function of Langerhans Cells In VivoImmunity, 2005